Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Long-Term Investments (2023 - 2025)

Rallybio's Long-Term Investments history spans 3 years, with the latest figure at $626000.0 for Q2 2025.

  • For Q2 2025, Long-Term Investments rose 10.21% year-over-year to $626000.0; the TTM value through Jun 2025 reached $626000.0, up 10.21%, while the annual FY2023 figure was $239000.0, N/A changed from the prior year.
  • Long-Term Investments for Q2 2025 was $626000.0 at Rallybio, up from $413000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $626000.0 in Q2 2025 and bottomed at $102000.0 in Q3 2023.
  • The 3-year median for Long-Term Investments is $358500.0 (2024), against an average of $362500.0.
  • The largest annual shift saw Long-Term Investments skyrocketed 322.55% in 2024 before it increased 10.21% in 2025.
  • A 3-year view of Long-Term Investments shows it stood at $239000.0 in 2023, then skyrocketed by 80.33% to $431000.0 in 2024, then soared by 45.24% to $626000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Long-Term Investments are $626000.0 (Q2 2025), $413000.0 (Q1 2025), and $431000.0 (Q3 2024).